MedMen to Acquire PharmaCann for $682 Million in Stock

MedMen Doubles Market Reach with Acquisition of PharmaCann
  • MedMen to acquire PharmaCann in all-stock transaction valued at US$682 million, the largest acquisition transaction in U.S. cannabis history.
  • The acquisition doubles the number of states where MedMen has licenses to 12.
  • The combined addressable market in these 12 states accounts for over 50 percent of the total estimated 2030 U.S. addressable market of $75 billion, according to Cowen Group.
  • Combined, MedMen and PharmaCann would be licensed for 66 retail stores and 13 cultivation and production facilities, including pending acquisitions by MedMen.
  • PharmaCann unitholders will own approximately 25 percent of the pro-forma company, on a fully-diluted basis, at closing.

All dollar values are in U.S. dollars, unless otherwise noted.

LOS ANGELES–(BUSINESS WIRE)–MedMen Enterprises Inc. (“MedMen” or the “Company”) (CSE: MMEN) (OTCQB: MMNFF) (FSE: A2JM6N) and Chicago-based PharmaCann LLC (“PharmaCann”) announced today that both

... read more at: https://www.newcannabisventures.com/medmen-to-acquire-pharmacann-for-682-million-in-stock/

by